Regional chemotherapy for pancreatic cancer

Regional chemotherapy for inoperable pan

Regional chemotherapy for inoperable pancreatic carcinoma

✍ James H. Muchmore; Janet E. Preslan; William J. George 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 932 KB

## BACKGROUND. Survival for adenocarcinoma of the pancreatic remains unchanged over the last two decades. The majority of patients (85%) are diagnosed with an inoperable tumor. Patterns of failure reveal that pancreatic cancer involves three compartments: the pancreatic bed and regional lymph nodes

Regional chemotherapy for inoperable pan

Regional chemotherapy for inoperable pancreatic carcinoma

✍ James H. Muchmore; Janet E. Preslan; William J. George 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 932 KB

## BACKGROUND. Survival for adenocarcinoma of the pancreatic remains unchanged over the last two decades. The majority of patients (85%) are diagnosed with an inoperable tumor. Patterns of failure reveal that pancreatic cancer involves three compartments: the pancreatic bed and regional lymph node

Regional cancer chemotherapy

✍ G. Westbury 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Regional cancer chemotherapy for advance

Regional cancer chemotherapy for advanced stage hepatocellular carcinoma

✍ Dr. Brian I. Carr; Shunzaburo Iwatsuki; Thomas E. Starzl; Rick Selby; Juan Madar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Chemotherapy for pancreatic carcinoma

✍ James D. Ahlgren 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

## BACKGROUND. Pancreatic cancer is an aggressive disease and its patients typically have a short survival, usually marked by pain and rapid debilitation. 'The disease has been considered relatively chemoresistant, although many chemotherapy regimens have been described. METHODS. Clinical results

Chemotherapy for pancreatic carcinoma

✍ James D. Ahlgren 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

## BACKGROUND. Pancreatic cancer is an aggressive disease and its patients typically have a short survival, usually marked by pain and rapid debilitation. 'The disease has been considered relatively chemoresistant, although many chemotherapy regimens have been described. METHODS. Clinical results